Literature DB >> 34411588

Opioid use disorder treatment in rural settings: The primary care perspective.

Valerie S Harder1, Andrea C Villanti2, Sarah H Heil3, M Lindsey Smith4, Diann E Gaalema3, Marjorie C Meyer5, Nathaniel H Schafrick6, Stacey C Sigmon3.   

Abstract

Despite the efficacy of medications for treating opioid use disorder (OUD), they are underutilized, especially in rural areas. Our objectives were to determine the association between primary care practitioners (PCPs) rurality and concerns for patient substance use, and to identify factors associated with PCP comfort treating OUD, focusing on barriers to treatment. We developed a web-based survey completed by 116 adult-serving PCPs located in Vermont's rural and non-rural counties between April-August 2020. The instrument included PCP-identified concerns for substance use among patients, barriers to treating patients with OUD, and current level of comfort treating patients with OUD. On a scale from 0 to 10, rural PCPs reported higher concern for heroin (mean difference; Mdiff = 1.38, 95% CI: 0.13 to 2.63), fentanyl (Mdiff = 1.52, 95% CI: 0.29 to 2.74), and methamphetamine (Mdiff = 1.61, 95% CI: 0.33 to 2.90) use among patients compared to non-rural PCPs, and practitioners in both settings expressed high concern regarding their patients' use of tobacco (7.6 out of 10) and alcohol (7.0 out of 10). There was no difference in reported comfort in treating patients with OUD among rural vs. non-rural PCPs (Mdiff = 0.65, 95%CI: 0.17 to 1.46; P = 0.119), controlling for higher comfort among male PCPs and those waivered to prescribe buprenorphine (Ps < 0.05). Lack of training/experience and medication diversion were PCP-identified barriers associated with less comfort treating OUD patients, while time constraints was associated with more comfort (Ps < 0.05). Taken together, these data highlight important areas for dissemination of evidence-based training, support, and resources to expand OUD treatment capacity in rural communities.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Buprenorphine; Opioid agonist treatment; Opioid use disorder; Opioids; Primary care practitioners; Rural; Treatment barriers and comfort

Mesh:

Substances:

Year:  2021        PMID: 34411588      PMCID: PMC8591995          DOI: 10.1016/j.ypmed.2021.106765

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  43 in total

1.  Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type.

Authors:  Leonard J Paulozzi; Yongli Xi
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-10       Impact factor: 2.890

2.  The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.

Authors:  Sharon Reif; Mary F Brolin; Maureen T Stewart; Thomas J Fuchs; Elizabeth Speaker; Shayna B Mazel
Journal:  J Subst Abuse Treat       Date:  2019-07-19

3.  Triage in opioid replacement therapy: what's the wait?

Authors:  Warren Harlow; Brenda Mary Happell; Graeme Browne; Jahar Choudhury; David Pinchin
Journal:  Subst Use Misuse       Date:  2012-11-05       Impact factor: 2.164

4.  U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018.

Authors:  Robin Ghertner
Journal:  Drug Alcohol Depend       Date:  2019-08-30       Impact factor: 4.492

5.  Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.

Authors:  Bradley D Stein; Rosalie Liccardo Pacula; Adam J Gordon; Rachel M Burns; Douglas L Leslie; Mark J Sorbero; Sebastian Bauhoff; Todd W Mandell; Andrew W Dick
Journal:  Milbank Q       Date:  2015-09       Impact factor: 4.911

6.  Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings.

Authors:  Paula J Lum; Sherri Little; Michael Botsko; David Hersh; Robert E Thawley; James E Egan; Jennifer Mitty; Joshua Boverman; David A Fiellin
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

7.  Comparison of characteristics of opioid-using pregnant women in rural and urban settings.

Authors:  Sarah H Heil; Stacey C Sigmon; Hendree E Jones; Michael Wagner
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

Review 8.  Opioid dependence treatment: options in pharmacotherapy.

Authors:  Angela L Stotts; Carrie L Dodrill; Thomas R Kosten
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

9.  Distance traveled and cross-state commuting to opioid treatment programs in the United States.

Authors:  Andrew Rosenblum; Charles M Cleland; Chunki Fong; Deborah J Kayman; Barbara Tempalski; Mark Parrino
Journal:  J Environ Public Health       Date:  2011-07-06

10.  Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US.

Authors:  Alexandra Duncan; Jared Anderman; Travis Deseran; Ian Reynolds; Bradley D Stein
Journal:  JAMA Netw Open       Date:  2020-08-03
View more
  3 in total

1.  Behavior change, health, and health disparities 2021: Rural addiction and health.

Authors:  Stephen T Higgins
Journal:  Prev Med       Date:  2021-10-07       Impact factor: 4.637

2.  Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities.

Authors:  P Todd Korthuis; Ryan R Cook; Canyon A Foot; Gillian Leichtling; Judith I Tsui; Thomas J Stopka; Judith Leahy; Wiley D Jenkins; Robin Baker; Brian Chan; Heidi M Crane; Hannah L Cooper; Judith Feinberg; William A Zule; Vivian F Go; Angela T Estadt; Robin M Nance; Gordon S Smith; Ryan P Westergaard; Brent Van Ham; Randall Brown; April M Young
Journal:  JAMA Netw Open       Date:  2022-08-01

3.  Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites.

Authors:  Dennis P Watson; Monte D Staton; Nicole Gastala
Journal:  Addict Sci Clin Pract       Date:  2022-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.